In a statement released Tuesday, IDSA and HIVMA endorsed the Trump administration’s new “15 Days to Slow the Spread” guidelines as a step forward in federal efforts to mitigate the impacts of COVID-19 across the United States.

As part of our response to COVID-19, IDSA has developed COVID-19 testing resources to help clinicians prioritize testing and understand testing options.

IDSA has continued to take a central role in ongoing policy discussions regarding access to diagnostics and regulation for laboratory developed tests. 

Listen now to IDSA's podcast series on COVID-19. The series aims to keep IDSA members, medical professionals and the public informed during this rapidly evolving public health crisis.

With the health and safety of our staff, members and the public in mind, IDSA has implemented a full-time telework schedule until further notice. Our commitment to serving our members will not be affected in any way, and you can still contact us as usual at info@idsociety.org. 

IDSA members and the Stakeholder Forum on Antimicrobial Resistance (S-FAR), which IDSA convenes, are urging Congress to support increased funding for federal antimicrobial resistance programs in 2021.  

The Centers for Disease Control and Prevention is requesting assistance from health care providers in responding to outbreaks of hepatitis A nationwide. 

IDSA, SHEA and PIDS are pleased to announce the 2021 awardees of the Leadership in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship. Now in its second iteration, the LEAP Fellowship is a $100,000 training grant competitively awarded to four promising young infectious diseases physicians.

The American Board of Internal Medicine recognizes that, as frontline health care professionals, many board-certified internists will experience significant personal and professional stress and disruption during the coming weeks as a result of the COVID-19 pandemic.